29 tracked 13F filers disclose a position in DMAA as of the latest SEC 13F filings, a combined $170.8M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Position value | Shares | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Karpus Management, Inc. | $26.5M | 2.5M | ▼−0.3% Reduced · −8K sh | Q1 2026 | |
| 2 | First Trust Capital Management L.P. | $23.5M | 2.2M | —Held | Q1 2026 | |
| 3 | Westchester Capital Management, LLC | $17.5M | 1.7M | —Held | Q1 2026 | |
| 4 | Polar Asset Management Partners Inc. | $16.8M | 1.6M | —Held | Q1 2026 | |
| 5 | HIGHBRIDGE CAPITAL MANAGEMENT LLC | $13.9M | 1.3M | ▲New +1.3M sh | Q1 2026 | |
| 6 | ARISTEIA CAPITAL, L.L.C. | $9.2M | 882K | —Held | Q1 2026 | |
| 7 | D. E. Shaw & Co., Inc. | $7.2M | 690K | —Held | Q1 2026 | |
| 8 | HEIGHTS CAPITAL MANAGEMENT, INC | $6.8M | 650K | —Held | Q1 2026 | |
| 9 | Shaolin Capital Management LLC | $5.8M | 550K | ▲+172% Added · +348K sh | Q1 2026 | |
| 10 | Radcliffe Capital Management, L.P. | $5.7M | 547K | —Held | Q1 2026 | |
| 11 | LMR Partners LLP | $5.2M | 500K | —Held | Q1 2026 | |
| 12 | RIVERNORTH CAPITAL MANAGEMENT, LLC | $4.4M | 418K | —Held | Q1 2026 | |
| 13 | WHITEBOX ADVISORS LLC | $4.2M | 400K | —Held | Q1 2026 | |
| 14 | METEORA CAPITAL, LLC | $4.0M | 380K | ▲New +380K sh | Q1 2026 | |
| 15 | AQR Arbitrage LLC | $3.8M | 358K | ▼−3.7% Reduced · −14K sh | Q1 2026 | |
| 16 | Clear Street Group Inc. | Withheld | 354K | ▲+8.6% Added · +28K sh | Q1 2026 | |
| 17 | Hudson Bay Capital Management LP | $3.1M | 298K | ▼−81% Reduced · −1.3M sh | Q1 2026 | |
| 18 | Quarry LP | $2.8M | 267K | —Held | Q1 2026 | |
| 19 | Governors Lane LP | $2.6M | 250K | —Held | Q1 2026 | |
| 20 | TORONTO DOMINION BANK | $2.1M | 204K | ▲+1.9% Added · +4K sh | Q1 2026 | |
| 21 | L1 Global Manager Pty Ltd | $2.1M | 200K | —Held | Q1 2026 | |
| 22 | GOLDMAN SACHS GROUP INC | $1.3M | 120K | —Held | Q1 2026 | |
| 23 | GEODE CAPITAL MANAGEMENT, LLC | $654K | 62K | ▲+36% Added · +17K sh | Q1 2026 | |
| 24 | JPMORGAN CHASE & CO | $523K | 50K | ▲+0.1% Added · +60 sh | Q1 2026 | |
| 25 | Dakota Wealth Management | $381K | 36K | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 3 funds opened a new position in DMAA and 1 added to an existing one, while 3 reduced and 0 exited entirely — based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Combined value |
|---|---|---|
| D. BORAL ARC ACQUISIT - CL ABCAR | 18 funds | $120.4M |
| REPUBLIC DIGITAL ACQUIS-CL ARDAG | 18 funds | $106.3M |
| ANDRETTI ACQUISITION CORP -APOLE | 18 funds | $95.8M |
| CAL REDWOOD ACQUISIT-CL ACRAQ | 18 funds | $93.8M |
| COLLECTIVE ACQUISITION CORPCCAQ | 18 funds | $65.6M |
| SOULPOWER ACQUISITION CO-ASOUL | 17 funds | $99.2M |
| NEW PROVIDENCE ACQUISITION-ANPAC | 17 funds | $99.0M |
| CANTOR EQUITY PARTNERS-CL ACEPV | 17 funds | $69.9M |
| GP-ACT III ACQUISITION-AGPAT | 16 funds | $150.6M |
| APEX TREASURY CORP-CL AAPXT | 16 funds | $131.5M |
| LEGATO MERGER CORP IIILEGT | 16 funds | $121.4M |
| IDEA ACQUISITION CORPIACOU | 16 funds | $119.3M |
Ranked by how many of DMAA's institutional holders also hold each name, a cross-fund conviction signal.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Feb 18, 2025 | Stockwell Lynn | CEO and Exe. Chair of Board, Director, 10% Owner | Buy (P) | 30K | — |
| Feb 18, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy (P) | 30K | — |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB, Director, 10% Owner | Sell (S) | 5.7M | — |
| Jan 29, 2025 | Stockwell Lynn | CEO and Executive COB, Director, 10% Owner | Buy (P) | 400K | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Buy (P) | 400K | — |
| Jan 29, 2025 | Drugs Made In America Acquisition LLC | 10% Owner | Sell (S) | 5.7M | — |
| Class | 13F holders | Value held |
|---|---|---|
| DMAAthis pageORD SHS | 29 funds | $172.1M |
| DMAARSPACS | 28 funds | $797K |
| DMAAUUNIT 10/15/2029 | 2 funds | $121K |
Same issuer, multiple share classes. The consensus leaderboards count this company once across all classes; this is the per-class detail.
Connected entities for DMAA
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/DMAA/capital-change-brief"
Use Arkolith's capital_change_brief for DMAA. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for DMAA. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.